Peptides DB
Research-centric peptide and protocol reference hub
Study 11 of 12GHRP-6 literatureVeterinary and animal science · Meta-analysis2026

The influence of zinc oxide utilization in ruminants: A systematic review and meta-analysis.

ZnO supplementation can significantly improve methane production and dry matter digestibility in ruminants, but the practical implications may vary based on specific conditions.

Read at Veterinary and animal scienceAdd to compare

Where it sits

this study against the rest of the ghrp-6 corpus
1
Preclinical
7
Observational
0
Open-label
1
Randomised
3
Reviews · this one

Summary and findings

This meta-analysis evaluated the effects of zinc oxide (ZnO) supplementation on rumen fermentation characteristics and productive performance in ruminants using 17 studies. ZnO supplementation significantly improved several parameters, including reducing methane production and increasing dry matter digestibility. The findings suggest that ZnO could enhance productivity in ruminant feeding systems.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
SMD = -1.281; 95% CI: -1.818 to -0.743; P < 0.001 for methane production reduction.2026

Abstract

The authors’ words, as Veterinary and animal science supplied them

Zinc (Zn) is an essential trace mineral involved in rumen microbial activity, nutrient metabolism, and animal productivity. This meta-analysis quantitatively evaluated the effects of ZnO supplementation on rumen fermentation characteristics, nutrient utilization, and productive performance in ruminants using 17 eligible studies published between 1971 and 2025. Standardized mean differences (SMD) were pooled using random-effects models. Heterogeneity was assessed using <i>I</i>² statistics, while subgroup analysis were performed according to ZnO form. Publication bias was evaluated using funnel plot inspection, Egger's regression test, and trim-and-fill correction. ZnO supplementation significantly improved several <i>in vitro</i> fermentation parameters by reducing methane production (SMD = -1.281; 95% CI: -1.818 to -0.743; P < 0.001), increasing propionate concentration (SMD = 0.521; P = 0.026), decreasing the acetate-to-propionate ratio (SMD = -1.226; P < 0.001), and increasing metabolizable energy (SMD = 2.034; P < 0.001). <i>In vivo</i>, ZnO supplementation reduced ruminal ammonia concentration (SMD = -0.869; P < 0.001) while increasing total volatile fatty acids (SMD = 0.520; P = 0.018), dry matter digestibility (SMD = 9.944; P < 0.001), average daily gain (SMD = 0.565; P = 0.004), dry matter intake (SMD = 0.649; P = 0.020), and alkaline phosphatase activity (SMD = 0.822; P = 0.033). Subgroup analysis revealed that nZnO consistently produced larger effect sizes for methane mitigation and growth responses than ZnO. Although publication bias was detected for methane outcomes, trim-and-fill analysis confirmed the robustness of the antimethanogenic effect (adjusted SMD = -1.082; P < 0.001). These findings provide quantitative evidence supporting that the supplementation of ZnO is a feasible option to improve productivity and sustainability in ruminant feeding systems.

Elsewhere in the GHRP-6 corpus

DEffects of light intensity on growth and leaf functional trait plasticity of &lt;i&gt;Paris polyphylla var. yunnanensis&lt;/i&gt;.Plant signaling & behavior · 2026 · 63.54-64.4 g rhizome fresh weight under 40%-60% natural light.BReference values for foot morphological characteristics: a cross-sectional study of urban Chinese children aged 9-36 months.Annals of human biology · 2026 · Median foot length increased from 11.29 cm to 15.07 cm in boys.HumanCGHRELIN IMPAIRS EMBRYO DEVELOPMENT AFTER OVARIAN HYPERSTIMULATION.The Journal of endocrinology · 2026 · Delay in embryo development at GD 3.5 reversed by (D-Lys3)-GHRP-6.AnimalAPhase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026 · mRS at 6 months for severe-stroke patients (NIHSS≥15) treated with EGF+GHRP6 was 2.6 (95%CI: 1.3-3.8) vs Control 4.7 (95%CI: 2.6-6); p=0.03.HumanDInforming policy through evidence: A scoping review of factors that influence enrolment in community-based health insurance in East Africa.europepmc · 2026reviewBMental health and legal statuses along the path to citizenship: A qualitative study of minority ethnic urban dwellers in Chiang Mai, Thailand.europepmc · 2026 · Not reported in abstract.Human